Search Results 451-460 of 24317 for B cell lymphomas
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Pagination Clinical studies. PrevPrevious ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma. Jacksonville, Fla ...
elogenous leukemia, Marginal zone lymphoma, B-cell lymphoma, Follicular lymphoma, Macroglobulinemia, Plasma cell disorders. Show more areas of focus for ...
... cells to kill cancer. CAR-T cell therapy has Food and Drug Administration approval for some B-cell lymphomas and leukemias and multiple myeloma, but not for CLL ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
... B-cell Lymphoma. Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville ... B-cell lymphoma with respect to PFS as assessed by the investigator.
... cell transplantation, and targeted therapy for hematologic malignancies. Conditions treated · B-cell lymphoma · Follicular lymphoma · Hodgkin lymphoma ...
Lymphoma could be regarded as a cancer of the white blood cells, cancer of the immune system or cancer of the blood, in essence, because of the origin of the ...
... B]. This Phase 3 study is designed to evaluate ... cell lymphoma that has come back or does not respond to treatment. ... A virus, called VSV-hIFNbeta-NIS, which ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!